Aldosterone and cardiovascular disease: The heart of the matter

B. Julie He, Mark Anderson

Research output: Contribution to journalArticle

Abstract

Aldosterone contributes to the endocrine basis of heart failure, and studies on cardiac aldosterone signaling have reinforced its value as a therapeutic target. Recent focus has shifted to new roles of aldosterone that appear to depend on coexisting pathologic stimuli, cell type, and disease etiology. This review evaluates recent advances in mechanisms underlying aldosterone-induced cardiac disease and highlights the interplay between aldosterone and Ca2+/calmodulin dependent protein kinase II, whose hyperactivity during heart failure contributes to disease progression. Increasing evidence implicates aldosterone in diastolic dysfunction, and there is a need to develop more targeted therapeutics such as aldosterone synthase inhibitors and molecularly specific antioxidants. Despite accumulating knowledge, many questions still persist and will likely dictate areas of future research.

Original languageEnglish (US)
Pages (from-to)21-30
Number of pages10
JournalTrends in Endocrinology and Metabolism
Volume24
Issue number1
DOIs
StatePublished - Jan 2013
Externally publishedYes

Fingerprint

Aldosterone
Cardiovascular Diseases
Heart Failure
Cytochrome P-450 CYP11B2
Calcium-Calmodulin-Dependent Protein Kinase Type 2
Disease Progression
Heart Diseases
Antioxidants
Therapeutics

Keywords

  • Aldosterone
  • CaMKII
  • Heart failure
  • Signaling

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Aldosterone and cardiovascular disease : The heart of the matter. / He, B. Julie; Anderson, Mark.

In: Trends in Endocrinology and Metabolism, Vol. 24, No. 1, 01.2013, p. 21-30.

Research output: Contribution to journalArticle

@article{41416f899c51402a8ede653ba275fa60,
title = "Aldosterone and cardiovascular disease: The heart of the matter",
abstract = "Aldosterone contributes to the endocrine basis of heart failure, and studies on cardiac aldosterone signaling have reinforced its value as a therapeutic target. Recent focus has shifted to new roles of aldosterone that appear to depend on coexisting pathologic stimuli, cell type, and disease etiology. This review evaluates recent advances in mechanisms underlying aldosterone-induced cardiac disease and highlights the interplay between aldosterone and Ca2+/calmodulin dependent protein kinase II, whose hyperactivity during heart failure contributes to disease progression. Increasing evidence implicates aldosterone in diastolic dysfunction, and there is a need to develop more targeted therapeutics such as aldosterone synthase inhibitors and molecularly specific antioxidants. Despite accumulating knowledge, many questions still persist and will likely dictate areas of future research.",
keywords = "Aldosterone, CaMKII, Heart failure, Signaling",
author = "He, {B. Julie} and Mark Anderson",
year = "2013",
month = "1",
doi = "10.1016/j.tem.2012.09.004",
language = "English (US)",
volume = "24",
pages = "21--30",
journal = "Trends in Endocrinology and Metabolism",
issn = "1043-2760",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Aldosterone and cardiovascular disease

T2 - The heart of the matter

AU - He, B. Julie

AU - Anderson, Mark

PY - 2013/1

Y1 - 2013/1

N2 - Aldosterone contributes to the endocrine basis of heart failure, and studies on cardiac aldosterone signaling have reinforced its value as a therapeutic target. Recent focus has shifted to new roles of aldosterone that appear to depend on coexisting pathologic stimuli, cell type, and disease etiology. This review evaluates recent advances in mechanisms underlying aldosterone-induced cardiac disease and highlights the interplay between aldosterone and Ca2+/calmodulin dependent protein kinase II, whose hyperactivity during heart failure contributes to disease progression. Increasing evidence implicates aldosterone in diastolic dysfunction, and there is a need to develop more targeted therapeutics such as aldosterone synthase inhibitors and molecularly specific antioxidants. Despite accumulating knowledge, many questions still persist and will likely dictate areas of future research.

AB - Aldosterone contributes to the endocrine basis of heart failure, and studies on cardiac aldosterone signaling have reinforced its value as a therapeutic target. Recent focus has shifted to new roles of aldosterone that appear to depend on coexisting pathologic stimuli, cell type, and disease etiology. This review evaluates recent advances in mechanisms underlying aldosterone-induced cardiac disease and highlights the interplay between aldosterone and Ca2+/calmodulin dependent protein kinase II, whose hyperactivity during heart failure contributes to disease progression. Increasing evidence implicates aldosterone in diastolic dysfunction, and there is a need to develop more targeted therapeutics such as aldosterone synthase inhibitors and molecularly specific antioxidants. Despite accumulating knowledge, many questions still persist and will likely dictate areas of future research.

KW - Aldosterone

KW - CaMKII

KW - Heart failure

KW - Signaling

UR - http://www.scopus.com/inward/record.url?scp=84871670499&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871670499&partnerID=8YFLogxK

U2 - 10.1016/j.tem.2012.09.004

DO - 10.1016/j.tem.2012.09.004

M3 - Article

C2 - 23040074

AN - SCOPUS:84871670499

VL - 24

SP - 21

EP - 30

JO - Trends in Endocrinology and Metabolism

JF - Trends in Endocrinology and Metabolism

SN - 1043-2760

IS - 1

ER -